(19)
(11) EP 1 343 515 A1

(12)

(43) Date of publication:
17.09.2003 Bulletin 2003/38

(21) Application number: 01979594.7

(22) Date of filing: 05.10.2001
(51) International Patent Classification (IPC)7: A61K 38/00, A61K 47/00, A61K 51/00, A61M 36/14, A01N 37/18
(86) International application number:
PCT/US0131/486
(87) International publication number:
WO 0202/8411 (11.04.2002 Gazette 2002/15)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 06.10.2000 US 238758 P
17.11.2000 US 249804 P
11.06.2001 US 297594 P
11.06.2001 US 297654 P
11.06.2001 US 297641 P

(71) Applicant: Xenoport, Inc.
Santa Clara, CA 95051-0703 (US)

(72) Inventors:
  • GALLOP, Mark A.
    Los Altos, CA 94022 (US)
  • CUNDY, Kenneth C.
    Redwood City, CA 94062 (US)

(74) Representative: Poulin, Gérard 
BREVALEX3, rue du Docteur Lancereaux
75008 Paris
75008 Paris (FR)

   


(54) COMPOUNDS FOR SUSTAINED RELEASE OF ORALLY DELIVERED DRUGS